ArticleCureus2026
A Lyme Neuroborreliosis Case Presenting With Ophthalmoplegia, Dysarthria, and Spastic Quadriparesis.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lyme neuroborreliosis (LNB) represents the neurological manifestation of Lyme disease and is the most common form of disseminated Lyme infection in Europe. Central nervous system involvement in LNB includes cranial neuritis, meningitis, radiculoneuritis, encephalitis, and encephalomyelitis with quadriparesis. We report a patient presenting with complex ophthalmoplegia, speech impairment, and spastic quadriparesis. The neurological weakness initially followed an ascending pattern suggestive of Guillain-Barré syndrome (GBS). Cerebrospinal fluid (CSF) analysis revealed lymphocytic pleocytosis, and serum testing showed positivity for immunoglobulin G (IgG) antibodies to Borrelia P39 and variable major protein-like sequence expressed (VlsE) antigens. IgG and immunoglobulin M (IgM) immunoblots were also positive. The patient was initially treated with intravenous immunoglobulin (IVIG) for presumed GBS and subsequently received antibiotics following CSF findings indicative of central nervous system infection, with subsequent neurological improvement. This case highlights the diagnostic challenges of LNB and underscores the importance of thorough evaluation of clinical history, neurological examination, and laboratory investigations to achieve diagnostic accuracy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.